Back to search

Article

Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agents

2022-04-26

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Administration of plasma therapy may contribute to viral control and survival of COVID-19 patients receiving B-cell depleting agents that hinder the endogenous humoral response. However, little is known on the impact of anti-CD20 pre-exposition and the use of different sources of plasma (convalescent versus vaccinated) on the kinetics of SARS-CoV-2-specific antibodies and vira...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
794c1d1f-1f37-5133-9e7b-51f768504c01
DOI
10.1101/2022.04.24.22274200
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Antibody response and intra-host viral evolution after plasma therapy in COVID-19 patients pre-exposed or not to B-cell depleting agentsDOI 10.1101/2022.04.24.22274200
Select a neighboring publication to make it the new centre.